SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE"

Transcription

1 SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE Summary Heart failure has a worse prognosis than many cancers with an annual mortality of 40% in the first year following diagnosis and 10% thereafter. Accurate and timely diagnosis is therefore important and echocardiography is mandatory. CAUSES OF HEART FAILURE Common causes of heart failure are Coronary heart disease and myocardial infarction (most common cause). Hypertension. Valvular heart disease These conditions generally cause left ventricular systolic dysfunction although hypertension can cause diastolic heart failure while mitral stenosis is usually associated with normal left ventricular function. Other causes of left ventricular systolic dysfunction include alcoholic cardiomyopathy, dilated cardiomyopathy and myocarditis. Heart failure can also be secondary to diseases that are not typically associated with left ventricular systolic dysfunction and examples are pericardial disease, hypertrophic cardiomyopathy and infilterative disorders such as amyloidosis and sarcoidosis. The reason for making a distinction between heart failure due to left ventricular systolic dysfunction and other types is that there are differences in treatment. The pharmacological recommendations in the NICE guidelines are directed at patients with left ventricular systolic dysfunction and patients with other types of heart failure should be seen and assessed by cardiologists. Symptoms The most common symptoms are Breathlessness Fatigue Exercise intolerance Peripheral oedema SYMPTOMS AND SIGNS OF HEART FAILURE St. Richard s Hospital Unfortunately, these symptoms are not unique to heart failure and are frequently seen in patients presenting to primary care. Other conditions which may present with some or all of these symptoms include obesity, chest disease, venous insufficiency, drug induced ankle swelling (e.g. calcium antagonists) or fluid retention (e.g. NSAIDs), hypoalbuminaemia and renal or hepatic disease. Other symptoms of heart failure include nocturia, anorexia, abdominal bloating and discomfort, constipation, and cerebral symptoms such as confusion, dizziness and memory impairment. Signs

2 Raised JVP (high predictive value but may not be present especially if patient on diuretics) Gallop rhythm Displaced apex Peripheral oedema As with the symptoms, the signs are not unique to heart failure but generally, the more symptoms and signs that are present, the more confident that a diagnosis of heart failure can be made. However, investigations are required to confirm the diagnosis. THE DIAGNOSIS OF HEART FAILURE If a detailed history and clinical examination suggests a diagnosis of heart failure, then confirmatory investigations are required (Figure 1). In one study, less than half the patients treated for heart failure in general practice had the disease. A normal ECG is very reassuring and we can be 98% sure that a patient does not have heart failure. Measurement of serum BNP (brain natriuretic peptide) has been introduced recently and can also be used to help diagnose heart failure. A negative result is useful in excluding heart failure. It can be seen that a normal ECG and a negative BNP result can be used to exclude heart failure this means referral for echocardiography maybe more selective and should be taken into consideration when investigating the patient. However, BNP assays are expensive and factors such as the ready availability of echocardiography should be considered. Locally, the waiting time for open access echocardiography is 2 3 weeks, therefore at present we are not advocating BNP. Echocardiography is extremely useful for the assessment of the structure and function of the heart and its valves. Sometimes, the quality of the images is suboptimal and alternative imaging techniques are required. HEART FAILURE? History and Examination Request Investigations ECG, Chest X-Ray, Blood Tests Start Diuretics if clinically indicated If investigations abnormal/indicative of heart failure REQUEST ECHO. Direct Referral to Echo Service For Routine Investigation Refer to Cardiology clinic for specialist opinion and echo if: Severe symptoms Heart Murmur The diagnosis is still unclear There is complex concomitant disease There is severe left ventricular dysfunction The patient may be considered a suitable candidate for transplant THE TREATMENT OF HEART FAILURE

3 This section deals with the treatment of patients with left ventricular systolic dysfunction. Diuretics. These are used for the relief of congestive symptoms and fluid retention (figure1) Loop diuretics such as frusemide are commonly used while thiazides such as bendrofluazide and metolazone can be added (often temporarily) to increase diuresis. Dosage is titrated against symptoms and body weight and serum electrolytes need to be monitored. Combination or high dose diuretics increase the risk of hypokalaemia and renal impairment. ACE inhibitors. All patients should be considered for treatment with ACE inhibitors, which should be started before beta-blockers. Treatment should be initiated at the relevant low dose and the dose increased at 2 weekly intervals so long as biochemistry, blood pressure and side effects allow. In hospital, where there is close monitoring, dosages can be increased daily. Examples of target dosages that have been used in clinical trials are Captopril 50 mg tds, Enalapril 20mg bd, Lisinopril 30mg od and Ramipril 10mg od. For other ACE inhibitors, the target doses are based on manufacturers recommendations rather than from outcome studies. Care and close supervision are required before initiating ACE inhibitors in patients with a serum creatinine > 200µmol/l or a potassium > 5.0mmol/l or a systolic blood pressure < 80mmHg. An increase in creatinine of up to 50% above baseline, or to 200 µmol/l, whichever is the smaller, is acceptable as is an increase in potassium to 5.9 mmol/l. Beta Blockers. The beta blockers licensed for heart failure are bisoprolol and carvedilol and these should be initiated after ACE inhibitors regardless of whether the patient is symptomatic or not. The rule is start low, go slow and heart rate, blood pressure and clinical status should be checked before each dose increase. If patients were already on a beta-blocker prior to developing heart failure, it is acceptable to continue with the existing beta-blocker.(nurse led Heart Failure Clinic) Spironolactone. Patients who remain moderately symptomatic and who are already on diuretics, ACE inhibitors and beta blockers can be commenced on Spironolactone at a dose of 25mg od. It is important to closely monitor the serum potassium and creatinine levels. Digoxin. This should be considered in anyone with atrial fibrillation or in those with severe heart failure despite the above treatment. (usualy introduced by specialist) Other drugs. The majority of patients will have coronary heart disease and may require other drugs such as aspirin and statins. Warfarin should be considered in those with atrial fibrillation and those assessed as being at risk for left ventricular thrombus formation. Calcium antagonists that are negatively inotropic should be avoided but amlodipine can be used. Angiotensin II receptor antagonists are not licensed for heart failure but can be used if patients are intolerant of ACE inhibitors. Heart Failure Nurse Specialist. Patients with heart failure are often on sub-optimal treatment. For instance, it is estimated that as few as 10% of patients are on betablockers. Two hospital heart failure nurse specialists are based on Charlton Ward, St. Richard s Hospital. Heart failure nurse specialists have been shown to reduce hospital admission rates by educating patients about their condition and by giving timely management advice when their clinic status is deteriorating. Lifestyle. Patients should be advised to give up smoking and patients with alcoholic cardiomyopathy should abstain from drinking. Regular aerobic and resistive exercise can improve symptoms and exercise tolerance. Overweight patients should lose weight aiming for a BMI of 25 to 30. Vaccination. Annual vaccination against influenza is recommended as is vaccination against pneumococcal disease (required once). Cardiac Resynchronisation Therapy. Biventricular pacemakers have been shown in some studies to improve symptoms and to reduce hospitalisations for heart failure. Pending studies investigating their effect on long-term survival, NICE has

4 made no firm recommendations about their prescription. Current indications are those patients with left ventricular ejection fraction 35%, drug refractory symptoms and a QRS duration > 120ms. Implantable cardioverter-defibrillators (ICDs). Up to 50% of heart failure patients die suddenly from cardiac arrest rather than from pump failure. ICDs are recommended for those who have survived a cardiac arrest due to VT or VF or who have had sustained VT that was haemodynamically significant 5. Figure 1. Algorithm for the pharmacological treatment of symptomatic heart failure due to left ventricular systolic dysfunction (from NICE guidelines for the management of chronic heart failure). Generalist New diagnosis Add Diuretic Diurectic therapy is likely to be required to control congestive symptoms and fluid retention Start ACE inhibitor and titrate upwards Or if ACE inhibitor not tolerated (eg due to severe cough) Consider angiotensin-ll receptor antagonist Specialist input Add Digoxin If a patient in sinus rhythm remains symptomatic despite therapy with a diurectic, ACE inhibitor (or angiotensin in receptor antagonist) and beta blocker. OR if a patient is in atrial fibrillation then use as first line therapy Add beta-blocker and titrate upwards Add spironolactone If patient remains moderately to severely symptomatic despite optimal drug therapy listed above Seek specialist advice for further options Specialist REFERRAL TO A CARDIOLOGIST Referral to a cardiologist should be considered in the following circumstances When there is a cardiac murmur indicating valvular heart disease or other lesion.

5 For assessment of any underlying coronary heart disease especially if angina is poorly controlled. When heart failure is difficult to manage e.g. requiring high dose diuretics or patient is intolerant of medication. When the cause of heart failure is other than left ventricular systolic dysfunction e.g. diastolic heart failure, restrictive cardiomyopathy and pericardial disease. If patients are suitable candidates for cardiac transplantation, cardiac resynchronisation therapy or implantable cardioverter-defibrillators. If patients have significant co-morbidity. PALLIATIVE CARE Palliative care has been a relatively neglected part of the management of patients with heart failure. The main areas of need include Symptom control. Psychological and social support. o Intensive Care at Home o Recently established Heart Support Group Planning for the future End of life care General palliative care can be delivered by the usual professional carers but specialist advice may be required from professionals with palliative care skills. REFERENCES Davie AP et al. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ 1996;312:222 Hobbs FDR et al. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure:cohort study in representative and high risk community populations. BMJ 2002;324:1-5 Developing services for heart failure. Department of Health Publications. Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care. Clinical Guideline 5. National Institute for Clinical Excellence. Guidance on the use of implantable cardioverter defibrillators for arrhythmias. NICE Technology Appraisal Guidance No AUTHOR: Dr Yuk-ki Wong, Consultant Cardiologist, St Richard s Hospital, Chichester. OTHERS INVOLVED: Consensus reached by Consultant Physician Colleagues Dr Colin Reid and Dr Conrad Murphy, Dietetics Department, & CCU at St Richard's Hospital, The Royal West Sussex Trust, Chichester. All LRMG Committee. PUBLISHED: 7/97 REVIEWED & UPDATED: 04/00, 06/04, 12/07 NEXT REVIEW: 12/09

Stockport Integrated Heart Failure Service. Heart Failure - a Guide to Investigation and Management in Primary Care

Stockport Integrated Heart Failure Service. Heart Failure - a Guide to Investigation and Management in Primary Care Stockport Integrated Heart Failure Service Heart Failure - a Guide to Investigation and Management in Primary Care 1 Stockport Heart Failure Referral and Diagnosis Pathway 2 Stockport Heart Failure Management

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

Hypertension Guidelines

Hypertension Guidelines Overview Hypertension Guidelines Aim to reduce Blood Pressure to 140/90 or less (140/80 for diabetics), adding drugs as needed until further treatment is inappropriate or declined. N.B. patients do not

More information

Clinical Pathway for the Assessment of Breathlessness (Shortness of Breath)

Clinical Pathway for the Assessment of Breathlessness (Shortness of Breath) Clinical Pathway for the Assessment of Breathlessness (Shortness of Breath) Introduction The main symptom of breathlessness, also described as shortness of breath (SOB), is a common symptomatology in the

More information

Causes & Treatments of Heart Failure

Causes & Treatments of Heart Failure Causes & Treatments of Heart Failure Usually heart failure is due to a primary cause as well as additional contributing causes Identifying and treating these causes are important in all types of heart

More information

MINISTRY OF HEALTH AND LONG-TERM CARE Primary Health Care Team FACT SHEET

MINISTRY OF HEALTH AND LONG-TERM CARE Primary Health Care Team FACT SHEET Title: Date: April 2008 MINISTRY OF HEALTH AND LONG-TERM CARE Primary Health Care Team FACT SHEET HEART FAILURE MANAGEMENT INCENTIVE Eligible Patient Enrolment Models (PEMs): Family Health Networks (FHNs)

More information

HEART FAILURE (HF) AND YOUR TREATMENT PLAN

HEART FAILURE (HF) AND YOUR TREATMENT PLAN HEART FAILURE AND YOUR TREATMENT PLAN JOHN MUIR HEALTH HEART FAILURE (HF) AND YOUR TREATMENT PLAN INTRODUCTION It is possible to lead a normal active life, even if you have heart failure. Taking control

More information

Department of Cardiology Royal Berkshire Hospital. Heart Failure. Information for patients

Department of Cardiology Royal Berkshire Hospital. Heart Failure. Information for patients Department of Cardiology Royal Berkshire Hospital Heart Failure Information for patients Introduction Heart failure can be caused by various heart conditions, which can be treated in different ways, to

More information

Automatic External Defibrillators

Automatic External Defibrillators Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Tackling the Semantic Interoperability challenge

Tackling the Semantic Interoperability challenge European Patient Summaries: What is next? Tackling the Semantic Interoperability challenge Dipak Kalra Cross-border health care The context for sharing health summaries Also useful for within-border health

More information

Case Study 8: Heart Failure

Case Study 8: Heart Failure Case Study 8: Heart Failure April 2000 Scenario Mr James is a 68 year old man who presents to you for the first time complaining of increasing shortness of breath on exertion. He was prescribed frusemide

More information

FACTS ABOUT HEART FAILURE

FACTS ABOUT HEART FAILURE Chattanooga Heart, Lung and Vascular Center Telephone: (423) 693-2400 1032 McCallie Avenue Facsimile: (423) 693-2499 Chattanooga, TN 37403-2815 CardiacAndVascular.com Table of Contents What is heart failure?

More information

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39 Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic

More information

The new Heart Failure pathway

The new Heart Failure pathway The new Heart Failure pathway An integrated and seamless Strategy Dr Sunil Balani Definition of Heart Failure The inability of the heart to pump blood at a rate commensurate with the requirements of metabolising

More information

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

HYPERTENSION ASSOCIATED WITH RENAL DISEASES RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein

More information

Cardiovascular Risk in Diabetes

Cardiovascular Risk in Diabetes Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,

More information

Diagnosis and management of chronic heart failure

Diagnosis and management of chronic heart failure Quick reference guide for health professionals Diagnosis and management of chronic heart failure Updated October 2011 This quick reference guide is derived from the National Heart Foundation of Australia

More information

Case Study 6: Management of Hypertension

Case Study 6: Management of Hypertension Case Study 6: Management of Hypertension 2000 Scenario Mr Ellis is a fit 61-year-old, semi-retired market gardener. He is a moderate (10/day) smoker with minimal alcohol intake and there are no other cardiovascular

More information

A Patients Guide to Heart Failure

A Patients Guide to Heart Failure A Patients Guide to Heart Failure Exceptional healthcare, personally delivered Heart Failure The term heart failure means that your heart is weakened and is having difficulty in pumping as hard as it would

More information

1 Congestive Heart Failure & its Pharmacological Management

1 Congestive Heart Failure & its Pharmacological Management Harvard-MIT Division of Health Sciences and Technology HST.151: Principles of Pharmocology Instructor: Prof. Keith Baker 1 Congestive Heart Failure & its Pharmacological Management Keith Baker, M.D., Ph.D.

More information

HYPERTROPHIC CARDIOMYOPATHY

HYPERTROPHIC CARDIOMYOPATHY HYPERTROPHIC CARDIOMYOPATHY Most often diagnosed during infancy or adolescence, hypertrophic cardiomyopathy (HCM) is the second most common form of heart muscle disease, is usually genetically transmitted,

More information

DILATED CARDIOMYOPATHY

DILATED CARDIOMYOPATHY DILATED CARDIOMYOPATHY Dilated or congestive cardiomyopathy (DCM) is diagnosed when the heart is enlarged (dilated) and the pumping chambers contract poorly (usually left side worse than right). A diagram

More information

The development of a pathway to support the management of patients requiring palliative care are ongoing.

The development of a pathway to support the management of patients requiring palliative care are ongoing. South East Wales Cardiac Network Model Pathway for Heart Failure CHD NSF Key Action 25 Introductory statement This pathway has been developed in line with the document 'Tackling CHD in Wales: Implementing

More information

PASSPORT. To living with HEART FAILURE

PASSPORT. To living with HEART FAILURE IL32 PASSPORT To living with HEART FAILURE Page 1 of 19 This booklet has been written to help you understand what heart failure is, how it may affect you, and what you can do to still make the most out

More information

Dorset Cardiac Centre

Dorset Cardiac Centre P a g e 1 Dorset Cardiac Centre Patients with Atrial Fibrillation/Flutter undergoing DC Cardioversion or Ablation procedures- Guidelines for Novel Oral Anti-coagulants (NOACS) licensed for this use February

More information

Hypertension and Heart Failure Medications. Dr William Dooley

Hypertension and Heart Failure Medications. Dr William Dooley Hypertension and Heart Failure Medications Dr William Dooley Plan Heart Failure Acute vs. chronic Mx Hypertension Common drugs used Method of action Choice of medications Heart Failure Aims; Short term:

More information

The clinical specialists view CARDIOLOGY

The clinical specialists view CARDIOLOGY 1st Symposium of the Amyloidosis Network The clinical specialists view CARDIOLOGY Andreas Flammer, MD, FESC University Heart Center Zurich Switzerland andreas.flammer@usz.ch Types of Amyloidosis affecting

More information

Heart Failure Outpatient Clinical Pathway

Heart Failure Outpatient Clinical Pathway Heart Failure Outpatient Clinical Pathway PHASE 1: PHASE 2: PHASE 3: PHASE 4: Initial Consult and Treatment Optimization of Therapy Reassessment and Further Optimization Maintenance I. Provider II. Consults

More information

RESTRICTIVE CARDIOMYOPATHY

RESTRICTIVE CARDIOMYOPATHY RESTRICTIVE CARDIOMYOPATHY Restrictive cardiomyopathy (RCM) is a rare form of heart muscle disease that is characterized by restrictive filling of the ventricles. In this disease the contractile function

More information

Heart Disease: Diagnosis & Treatment

Heart Disease: Diagnosis & Treatment How I Treat Cardiology Peer Reviewed Heart Disease: Diagnosis & Treatment Amara Estrada, DVM, DACVIM (Cardiology) University of Florida Background Clinical heart disease is the stage of disease when a

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia

More information

Universitätsklinik für Kardiologie. Test. Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie thomas.suter@insel.ch 1

Universitätsklinik für Kardiologie. Test. Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie thomas.suter@insel.ch 1 Test Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie thomas.suter@insel.ch 1 Heart Failure - Definition European Heart Journal (2008) 29, 2388 2442 Akute Herzinsuffizienz Diagnostik und

More information

SIGN. Management of chronic heart failure. Scottish Intercollegiate Guidelines Network. A national clinical guideline

SIGN. Management of chronic heart failure. Scottish Intercollegiate Guidelines Network. A national clinical guideline SIGN Scottish Intercollegiate Guidelines Network Help us to improve SIGN guidelines - click here to complete our survey 95 Management of chronic heart failure A national clinical guideline 1 Introduction

More information

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF

More information

Cardiovascular System & Its Diseases. Lecture #4 Heart Failure & Cardiac Arrhythmias

Cardiovascular System & Its Diseases. Lecture #4 Heart Failure & Cardiac Arrhythmias Cardiovascular System & Its Diseases Lecture #4 Heart Failure & Cardiac Arrhythmias Dr. Derek Bowie, Department of Pharmacology & Therapeutics, Room 1317, McIntyre Bldg, McGill University derek.bowie@mcgill.ca

More information

LIVING WELL WITH HEART FAILURE

LIVING WELL WITH HEART FAILURE JOHN MUIR HEALTH How Does a Healthy Heart Work? What is Heart Failure (HF)? Summary of How Heart Failure Develops How is Heart Failure Diagnosed? Ejection Fraction and Its Importance Is There a Cure for

More information

Heart Failure: Diagnosis and Treatment

Heart Failure: Diagnosis and Treatment Heart Failure: Diagnosis and Treatment Approximately 5 million people about 2 percent of the U.S. population are affected by heart failure. Diabetes affects 20.8 million Americans and 65 million Americans

More information

GENERAL HEART DISEASE KNOW THE FACTS

GENERAL HEART DISEASE KNOW THE FACTS GENERAL HEART DISEASE KNOW THE FACTS WHAT IS Heart disease is a broad term meaning any disease affecting the heart. It is commonly used to refer to coronary heart disease (CHD), a more specific term to

More information

Endorsement Summary: Cardiovascular Measures

Endorsement Summary: Cardiovascular Measures January 2012 Purpose of the Project The human and financial costs of cardiovascular disease are enormous. Heart disease is the leading cause of death for men and women in the United States and was estimated

More information

Acute heart failure may be de novo or it may be a decompensation of chronic heart failure.

Acute heart failure may be de novo or it may be a decompensation of chronic heart failure. Management of Acute Left Ventricular Failure Acute left ventricular failure presents as pulmonary oedema due to increased pressure in the pulmonary capillaries. It is important to realise though that left

More information

Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI)

Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI) Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI) Highlights from Prescribing Information - the link to the full text PI is as follows: http://www.pharma.us.novartis.com/product/pi/pdf/gilenya.pdf

More information

TACHYCARDIA INDUCED CARDIOMYOPATHY. Case 1 ECG

TACHYCARDIA INDUCED CARDIOMYOPATHY. Case 1 ECG TACHYCARDIA INDUCED CARDIOMYOPATHY Javier E. Banchs M.D. Associate Professor of Medicine Penn State Hershey Heart & Vascular Institute Case 1 34 year old man with history of tachycardia x 6 months, nausea

More information

James F. Kravec, M.D., F.A.C.P

James F. Kravec, M.D., F.A.C.P James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE 1 NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Guideline title SCOPE Hypertension: clinical management of primary hypertension in adults 1.1 Short title Hypertension (partial update) 2 The remit

More information

Stroke Prevention & Atrial Fibrillation. Susanne Christie Arrhythmia Nurse Specialist 24 th September 2015

Stroke Prevention & Atrial Fibrillation. Susanne Christie Arrhythmia Nurse Specialist 24 th September 2015 Stroke Prevention & Atrial Fibrillation Susanne Christie Arrhythmia Nurse Specialist 24 th September 2015 Learning Outcomes What is Atrial Fibrillation? Why is Atrial Fibrillation important? What causes

More information

HEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise

HEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise WEEK 3 SUPPLEMENT HEART HEALTH A Beginner s Guide to Cardiovascular Disease HEART FAILURE Heart failure can be defined as the failing (insufficiency) of the heart as a mechanical pump due to either acute

More information

Rhythm control strategies for symptomatic atrial fibrillation Hemels, Martin Eric Willem

Rhythm control strategies for symptomatic atrial fibrillation Hemels, Martin Eric Willem Rhythm control strategies for symptomatic atrial fibrillation Hemels, Martin Eric Willem IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it.

More information

Protocol for the management of atrial fibrillation in primary care

Protocol for the management of atrial fibrillation in primary care Protocol for the management of atrial fibrillation in primary care Protocol for the management of atrial fibrillation in primary care Contents Page no Definition 2 Classification of AF 2 3 Identification

More information

NORTHERN NETWORK OF CARDIAC CARE GUIDELINES FOR THE DETECTION AND MANAGEMENT OF ATRIAL FIBRILLATION (AF)

NORTHERN NETWORK OF CARDIAC CARE GUIDELINES FOR THE DETECTION AND MANAGEMENT OF ATRIAL FIBRILLATION (AF) NORTHERN NETWORK OF CARDIAC CARE GUIDELINES FOR THE DETECTION AND MANAGEMENT OF ATRIAL FIBRILLATION (AF) These notes should be read in conjunction with the summary algorithms July 2007 CONTENTS 1. Introduction

More information

Atrial fibrillation. Quick reference guide. Issue date: June 2006. The management of atrial fibrillation

Atrial fibrillation. Quick reference guide. Issue date: June 2006. The management of atrial fibrillation Quick reference guide Issue date: June 2006 Atrial fibrillation The management of atrial fibrillation Developed by the National Collaborating Centre for Chronic Conditions Contents Contents Patient-centred

More information

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1

More information

The BEAUTIFUL Study Backgrounder

The BEAUTIFUL Study Backgrounder The BEAUTIFUL Study Backgrounder About the BEAUTIFUL study The BEAUTIFUL (MorBidity-mortality EvAlUaTion of the I f inhibitor Procoralan in patients with coronary disease and left ventricular dysfunction)

More information

Atrial Fibrillation An update on diagnosis and management

Atrial Fibrillation An update on diagnosis and management Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.

More information

MANAGEMENT OF HEART FAILURE with Reduced Ejection Fraction (HFREF)

MANAGEMENT OF HEART FAILURE with Reduced Ejection Fraction (HFREF) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF HEART FAILURE with Reduced Ejection Fraction (HFREF) All patients with HFREF should be considered for an ACE inhibitor and beta blocker.

More information

Heart failure in primary care with special emphasis on costs and benefits of a disease management programme

Heart failure in primary care with special emphasis on costs and benefits of a disease management programme Linköping University Medical Dissertations No. 1391. Heart failure in primary care with special emphasis on costs and benefits of a disease management programme Björn Agvall General Practice Department

More information

Bisoprolol in the Treatment of Heart Failure

Bisoprolol in the Treatment of Heart Failure Heart Failure Prescribing Guidelines Beta-Blocker Dose Titration Schedule Appendix 2A in the Treatment of Heart Failure Applicable to: All patients diagnosed with and commenced on bisoprolol. Patients

More information

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Chapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00-E89) The diabetes mellitus codes are combination codes

More information

To be completed and signed by the Attending Physician

To be completed and signed by the Attending Physician Instruction to doctor: This patient is insured with us against the happening of certain contingent events associated with his health. A claim has been submitted in connection with Heart attack / Cardiomyopathy

More information

Carvedilol in the Treatment of Heart Failure

Carvedilol in the Treatment of Heart Failure Appendix 2B Heart Failure Prescribing Guidelines Rotherham PCT Applicable to: Carvedilol in the Treatment of Heart Failure All patients diagnosed with and commenced on carvedilol. Patients not discharged

More information

This supplementary material has been provided by the authors to give readers additional information about their work.

This supplementary material has been provided by the authors to give readers additional information about their work. SUPPLEMENTAL MATERIAL Table S1. The logistic regression model used to calculate the propensity score. Table S2. Distribution of propensity score among the treat and control groups of the full and matched

More information

Atrial fibrillation and flutter in primary care

Atrial fibrillation and flutter in primary care Atrial fibrillation and flutter in primary care Atrial fibrillation is underdiagnosed and undertreated Atrial fibrillation or flutter (AF)* occurs in approximately 1% of the general population. The prevalence

More information

Anti-arrhythmic Drugs

Anti-arrhythmic Drugs Anti-arrhythmic Drugs Overview Review causes and features of cardiac arrhythmia The Vaughan-Williams classification of anti-arrhythmic drugs. Emergency Rx of arrhythmias Summary Drugs of choice for common

More information

Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8)

Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) Adapted by Capital Health Plan Approved by Quality Improvement

More information

Cardiomyopathy (Heart Disease) in Cats

Cardiomyopathy (Heart Disease) in Cats Cardiomyopathy (Heart Disease) in Cats PETVET clinics are well-equipped, full-service, small animal veterinary practices providing comprehensive diagnostic, medical, surgical and dental care. We aim to

More information

Atrial Fibrillation - management AF in primary care

Atrial Fibrillation - management AF in primary care Care map information Information resources for patients and carers Updates to this care map Hauora Maori Pacific Clinical presentation AF

More information

With an ageing population coupled with the growing

With an ageing population coupled with the growing PEER REVIEWED FEATURE 2 CPD POINTS Managing heart failure The key role of the GP ALEX VOSKOBOINIK MB BS (Hons) JUSTIN A. MARIANI MB BS, BMedSci, PhD, FRACP, FCSANZ Management of most patients with heart

More information

PERI ARREST ARRHYTHMIAS Anu Roy

PERI ARREST ARRHYTHMIAS Anu Roy PERI ARREST ARRHYTHMIAS Anu Roy BACKGROUND The term peri arrest arrhythmias are used to describe cardiac rhythm disorders that may precede cardiac arrest or follow initial resuscitation from a cardiac

More information

Arrhythmia Facts. Each day the average heart beats (expands and contracts) 100,000 times and pumps about 2,000 gallons of blood.

Arrhythmia Facts. Each day the average heart beats (expands and contracts) 100,000 times and pumps about 2,000 gallons of blood. Arrhythmia Facts During a 24-hour period, about 20% of healthy adults are likely to have frequent or multiple types of premature ventricular heartbeats. Heart arrhythmias are very common and nearly everyone

More information

KIH Cardiac Rehabilitation Program

KIH Cardiac Rehabilitation Program KIH Cardiac Rehabilitation Program For any further information Contact: +92-51-2870361-3, 2271154 Feedback@kih.com.pk What is Cardiac Rehabilitation Cardiac rehabilitation describes all measures used to

More information

Cost of treating heart failure in an Irish teaching hospital

Cost of treating heart failure in an Irish teaching hospital IJMS 2001;169(4):176-179 Cost of treating heart failure in an Irish teaching hospital McGowan B, Heerey A, Ryan M, Barry M. Correspondence to: Dr.Michael Barry. National Centre for Pharmacoeconomics, St.

More information

Chronic Kidney Disease (CKD)Management in General Practice SUMMARY GUIDE

Chronic Kidney Disease (CKD)Management in General Practice SUMMARY GUIDE Chronic Kidney Disease (CKD)Management in General Practice SUMMARY GUIDE Early detection of CKD using kidney health check Who is at higher risk of kidney disease? Age > 50 years Diabetes High blood pressure

More information

SYMPTOMS Heart failure symptoms may vary and can be hard to detect. Symptoms may include:

SYMPTOMS Heart failure symptoms may vary and can be hard to detect. Symptoms may include: Heart Failure Heart failure is a condition in which the heart has trouble pumping blood. This means your heart does not pump blood efficiently for your body to work well. In some cases of heart failure,

More information

Pulmonary Hypertension

Pulmonary Hypertension Pulmonary Hypertension Pulmonary Hypertension is a rare lung disease in which the blood pressure in the main artery (pulmonary artery) to your lungs is very high. This high pressure results in changes

More information

Inpatient Heart Failure Management: Risks & Benefits

Inpatient Heart Failure Management: Risks & Benefits Inpatient Heart Failure Management: Risks & Benefits Dr. Kenneth L. Baughman Professor of Medicine Harvard Medical School Director, Advanced Heart Disease Section Brigham & Women's Hospital Harvard Medical

More information

The heart then repolarises (or refills) in time for the next stimulus and contraction.

The heart then repolarises (or refills) in time for the next stimulus and contraction. Atrial Fibrillation BRIEFLY, HOW DOES THE HEART PUMP? The heart has four chambers. The upper chambers are called atria. One chamber is called an atrium, and the lower chambers are called ventricles. In

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

Heart disorders (acquired) - children

Heart disorders (acquired) - children Heart disorders (acquired) - children Summary An acquired heart defect develops in children after a disease. There are four types of acquired heart defect. All children with heart defects have special

More information

1 Heart failure Causes, diagnosis, signs and symptoms

1 Heart failure Causes, diagnosis, signs and symptoms 1 Heart failure Causes, diagnosis, signs and symptoms 1 The Heartbeat Trust is Ireland s national heart failure charity (CHY 5938). It supports specialist clinical and research services in heart failure

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

The-First-In-Man Randomized Trial of a ß3- adrenoceptor Agonist in Chronic Heart Failure BEAT-HF

The-First-In-Man Randomized Trial of a ß3- adrenoceptor Agonist in Chronic Heart Failure BEAT-HF The-First-In-Man Randomized Trial of a ß3- adrenoceptor Agonist in Chronic Heart Failure Henning Bundgaard, Anna Axelsson, Jakob H Thomsen, Mathias Sørgaard, Klaus Kofoed, Nana Køber, Rasmus B Hasselbalch,

More information

Manitoba Primary Care Quality Indicators Guide Plain Language Summary - v1.9.1

Manitoba Primary Care Quality Indicators Guide Plain Language Summary - v1.9.1 Manitoba Primary Care Quality Indicators Guide Plain Language Summary - v1.9.1 Prevention 2.01 Cervical Cancer Screening (CIHI Derived from indicator # 50) Percentage of female enrolled patients 21 to

More information

Atrial Fibrillation Peter Santucci, MD Revised May, 2008

Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial fibrillation (AF) is an irregular, disorganized rhythm characterized by a lack of organized mechanical atrial activity. The atrial rate is

More information

Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015

Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015 Atrial Fibrillation: Drugs, Ablation, or Benign Neglect Robert Kennedy, MD October 10, 2015 Definitions 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary.

More information

2013 ACO Quality Measures

2013 ACO Quality Measures ACO 1-7 Patient Satisfaction Survey Consumer Assessment of HealthCare Providers Survey (CAHPS) 1. Getting Timely Care, Appointments, Information 2. How well Your Providers Communicate 3. Patient Rating

More information

Atrial Fibrillation Overview for Staff of Community Primary and Specialty Care Providers

Atrial Fibrillation Overview for Staff of Community Primary and Specialty Care Providers Atrial Fibrillation Overview for Staff of Community Primary and Specialty Care Providers Atrial Fibrillation (AF or AFib) Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #5 (NQF 0081): Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) National Quality

More information

Hypertrophic and Dilated Cardiomyopathy. Rahul Deo, MD PHD Assistant Professor Division of Cardiology, UCSF Principal Investigator, CVRI

Hypertrophic and Dilated Cardiomyopathy. Rahul Deo, MD PHD Assistant Professor Division of Cardiology, UCSF Principal Investigator, CVRI Hypertrophic and Dilated Cardiomyopathy Rahul Deo, MD PHD Assistant Professor Division of Cardiology, UCSF Principal Investigator, CVRI Outline Definitions Epidemiology: the scope of the problem Genetics

More information

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below Name: generic (trade) Rivaroxaban (Xarelto ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below What it is Indications

More information

CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES

CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES CHRONIC KIDNEY DISEASE PRACTICE GUIDELINES Reviewed and approved 5/2014 Risk Chronic kidney disease is defined as either kidney damage or decreased kidney function (decreased GFR) for 3 or more months.

More information

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts Cardiac Rehabilitation: From the other side of the glass door No disclosures, no conflicts Charles X. Kim, MD, FACC, ABVM Objectives 1. Illustrate common CV benefits of CV rehab in real world practice.

More information

Concise Guide to the Management of Heart Failure

Concise Guide to the Management of Heart Failure Concise Guide to the Management of Heart Failure WORLD HEALTH ORGANIZATION/COUNCIL ON GERIATRIC CARDIOLOGY TASK FORCE ON HEART FAILURE EDUCATION CONTENTS WHO/CGC TASK FORCE ON Heart Failure EDUCATION...4

More information

Quiz 5 Heart Failure scores (n=163)

Quiz 5 Heart Failure scores (n=163) Quiz 5 Heart Failure summary statistics The correct answers to questions are indicated by *. Students were awarded 2 points for question #3 for either selecting spironolactone or eplerenone. However, the

More information

Guidelines for the management of hypertension in patients with diabetes mellitus

Guidelines for the management of hypertension in patients with diabetes mellitus Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes

More information

Drug Treatment in Type 2 Diabetes with Hypertension

Drug Treatment in Type 2 Diabetes with Hypertension Hypertension is 1.5 2 times more prevalent in Type 2 diabetes (prevalence up to 80 % in diabetic subjects). This exacerbates the risk of cardiovascular disease by ~ two-fold. Drug therapy reduces the risk

More information

GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT AND PREVENTION OF COPD

GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT AND PREVENTION OF COPD Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT

More information

COMMITTEE MEMBERS SHARON A. HUNT, MD, FACC, Chair SIDNEY GOLDSTEIN, MD, FACC MARSHALL H. CHIN, MD, MPH

COMMITTEE MEMBERS SHARON A. HUNT, MD, FACC, Chair SIDNEY GOLDSTEIN, MD, FACC MARSHALL H. CHIN, MD, MPH Journal of the American College of Cardiology Vol. 38, No. 7, 2001 2001 by the American College of Cardiology and the American Heart Association, Inc. ISSN 0735-1097/01/$20.00 Published by Elsevier Science

More information

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic. bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.

More information

Educational Goals & Objectives

Educational Goals & Objectives Educational Goals & Objectives The Cardiology rotation will provide the resident with an understanding of cardiovascular physiology and its broad systemic manifestations. The resident will have the opportunity

More information